Skip to main content
November 01, 2019
In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help prevent school shootings.
October 28, 2019
Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.
October 09, 2019
SAN DIEGO—While medications can address some of the symptoms of Alzheimer’s disease, maintaining a healthy lifestyle can delay its onset and slow progression of the disease, a geriatric psychiatry expert told attendees at Psych Congress 2019.
October 06, 2019
SAN DIEGO—There is no single profile of a school shooter, and potential threats must be evaluated based on the behavior of the student instead, forensic psychiatrist Phillip J. Resnick, MD, said at a Psych Congress 2019 Featured Session on school shooters.
October 05, 2019
SAN DIEGO—Mental health clinicians aren't talking to their patients enough about sexual dysfunction commonly associated with depression and its treatment, Anita Clayton. MD, stated at Psych Congress 2019.
October 05, 2019
SAN DIEGO—Psilocybin-assisted psychotherapy appears to have a beneficial and lasting effect on patient mood, but possible approval of the treatment remains some time away, a researcher said at Psych Congress 2019.
October 05, 2019
SAN DIEGO—A year’s treatment with the investigational drug ALKS 3831 was generally well-tolerated and demonstrated a safety profile that supports long-term use, according to study findings presented at Psych Congress 2019.
October 05, 2019
SAN DIEGO—Cannabidiol (CBD) has quickly entered the mainstream, but there is a dearth of evidence about the effects of the cannabis byproduct, a speaker told a large audience at Psych Congress 2019.
October 05, 2019
SAN DIEGO—The opioid withdrawal drug lofexidine demonstrated statistically significant efficacy across a half-dozen patient- and clinician-reported outcomes during the first 7 days after immediate opioid cessation, according to study presented at Psych Congress 2019.
October 05, 2019
SAN DIEGO—Children with bipolar disorder who were treated with lurasidone had a lower risk of all-cause and psychiatric-related hospitalization than those treated with aripiprazole or olanzapine, according to a retrospective claims database study.
Back to Top